Friday, May 9, 2025
No Result
View All Result
Volume 2, Issue 2
International Myeloma Society
  • Home
  • Letter From the President
  • COVID Corner
  • Research Spotlight
  • Meeting Updates
  • Contact
  • Home
  • Letter From the President
  • COVID Corner
  • Research Spotlight
  • Meeting Updates
  • Contact
No Result
View All Result
International Myeloma Society
No Result
View All Result
Home Uncategorized

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

Jesus San Miguel, MD and Evangelos Terpos, MD

August 9, 2023
in Uncategorized

Sign Up to Our Newsletter

Popular Articles

  • IMS Annual Meeting 2022: Relapsed MM

    IMS Annual Meeting 2022: Relapsed MM

    0 shares
    Share 0 Tweet 0
  • Photo of the Issue – Loire Valley

    0 shares
    Share 0 Tweet 0
  • IMS Annual Meeting 2022: High Risk MM

    0 shares
    Share 0 Tweet 0
  • A conversation with Maria Victoria Mateos, MD, PhD, recipient of the 2022 Bart Barlogie Clinical Investigator Award

    0 shares
    Share 0 Tweet 0
  • IMS Annual Meeting 2022: Induction for Newly Diagnosed Myeloma

    0 shares
    Share 0 Tweet 0
  • Home
  • Letter From the President
  • Contact

© 2022 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.

No Result
View All Result
  • Contact
  • Home

© 2022 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.